CONNECT BIOPHARMA HLDGS LTD's ticker is CNTB and the CUSIP is 207523101. A total of 17 filers reported holding CONNECT BIOPHARMA HLDGS LTD in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $532,350 | -27.5% | 650,000 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $734,500 | -28.5% | 650,000 | -36.7% | 0.00% | 0.0% |
| Q1 2023 | $1,027,416 | +15.2% | 1,027,519 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $891,681 | -45.9% | 1,027,519 | -19.6% | 0.00% | -50.0% |
| Q3 2022 | $1,648,000 | +13.0% | 1,277,519 | -23.8% | 0.00% | +33.3% |
| Q2 2022 | $1,459,000 | -66.4% | 1,677,519 | +16.7% | 0.00% | -62.5% |
| Q1 2022 | $4,341,000 | -32.6% | 1,437,500 | +15.0% | 0.01% | -33.3% |
| Q4 2021 | $6,438,000 | – | 1,250,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 597,678 | $771,000 | 0.24% |
| Kynam Capital Management, LP | 739,649 | $954,000 | 0.20% |
| RA Capital Management | 6,991,003 | $9,018,000 | 0.19% |
| Octagon Capital Advisors LP | 450,000 | $581,000 | 0.10% |
| Ikarian Capital, LLC | 219,501 | $283,000 | 0.06% |
| UBS OCONNOR LLC | 613,931 | $792,000,000 | 0.02% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,277,519 | $1,648,000 | 0.00% |
| ROCKY MOUNTAIN ADVISERS, LLC | 1,200 | $2,000 | 0.00% |
| CSS LLC/IL | 38,721 | $50,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 26,867 | $35,000 | 0.00% |